Rodent models for nicotine withdrawal
- PMID:33888006
- PMCID: PMC8526373
- DOI: 10.1177/02698811211005629
Rodent models for nicotine withdrawal
Abstract
Background: Animal models are critical to improve our understanding of the neuronal mechanisms underlying nicotine withdrawal. Nicotine dependence in rodents can be established by repeated nicotine injections, chronic nicotine infusion via osmotic minipumps, oral nicotine intake, tobacco smoke exposure, nicotine vapor exposure, and e-cigarette aerosol exposure. The time course of nicotine withdrawal symptoms associated with these methods has not been reviewed in the literature.
Aim: The goal of this review is to discuss nicotine withdrawal symptoms associated with the cessation of nicotine, tobacco smoke, nicotine vapor, and e-cigarette aerosol exposure in rats and mice. Furthermore, age and sex differences in nicotine withdrawal symptoms are reviewed.
Results: Cessation of nicotine, tobacco smoke, nicotine vapor, and e-cigarette aerosol exposure leads to nicotine withdrawal symptoms such as somatic withdrawal signs, changes in locomotor activity, anxiety- and depressive-like behavior, learning and memory deficits, attention deficits, hyperalgesia, and dysphoria. These withdrawal symptoms are most pronounced within the first week after cessation of nicotine exposure. Anxiety- and depressive-like behavior, and deficits in learning and memory may persist for several months. Adolescent (4-6 weeks old) rats and mice display fewer nicotine withdrawal symptoms than adults (>8 weeks old). In adult rats and mice, females show fewer nicotine withdrawal symptoms than males. The smoking cessation drugs bupropion and varenicline reduce nicotine withdrawal symptoms in rodents.
Conclusion: The nicotine withdrawal symptoms that are observed in rodents are similar to those observed in humans. Tobacco smoke and e-cigarette aerosol contain chemicals and added flavors that enhance the reinforcing properties of nicotine. Therefore, more valid animal models of tobacco and e-cigarette use need to be developed by using tobacco smoke and e-cigarette aerosol exposure methods to induce dependence.
Keywords: Nicotine; dependence; e-cigarettes; mecamylamine; precipitated; smoke; smoking cessation; spontaneous; tobacco; vapor; withdrawal.
Conflict of interest statement
Conflict of interest
The authors declare that there is no conflict of interest.
Figures
Similar articles
- Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in mice.Ponzoni L, Moretti M, Sala M, Fasoli F, Mucchietto V, Lucini V, Cannazza G, Gallesi G, Castellana CN, Clementi F, Zoli M, Gotti C, Braida D.Ponzoni L, et al.Eur Neuropsychopharmacol. 2015 Oct;25(10):1775-86. doi: 10.1016/j.euroneuro.2015.06.010. Epub 2015 Jun 20.Eur Neuropsychopharmacol. 2015.PMID:26141510
- Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal.Wing VC, Shoaib M.Wing VC, et al.Psychopharmacology (Berl). 2007 Dec;195(3):303-13. doi: 10.1007/s00213-007-0902-0. Epub 2007 Aug 10.Psychopharmacology (Berl). 2007.PMID:17690868
- Exposure to smoke from high- but not low-nicotine cigarettes leads to signs of dependence in male rats and potentiates the effects of nicotine in female rats.Chellian R, Behnood-Rod A, Wilson R, Wilks I, Knight P, Febo M, Bruijnzeel AW.Chellian R, et al.Pharmacol Biochem Behav. 2020 Sep;196:172998. doi: 10.1016/j.pbb.2020.172998. Epub 2020 Jul 16.Pharmacol Biochem Behav. 2020.PMID:32681850Free PMC article.
- Development of Dependence in Smokers and Rodents With Voluntary Nicotine Intake: Similarities and Differences.Chellian R, Behnood-Rod A, Bruijnzeel AW.Chellian R, et al.Nicotine Tob Res. 2023 Jun 9;25(7):1229-1240. doi: 10.1093/ntr/ntac280.Nicotine Tob Res. 2023.PMID:36482774Free PMC article.Review.
- Rodent models of nicotine withdrawal syndrome.Malin DH, Goyarzu P.Malin DH, et al.Handb Exp Pharmacol. 2009;(192):401-34. doi: 10.1007/978-3-540-69248-5_14.Handb Exp Pharmacol. 2009.PMID:19184657Review.
Cited by
- Enhancing translation: A need to leverage complex preclinical models of addictive drugs to accelerate substance use treatment options.Corley C, Craig A, Sadek S, Marusich JA, Chehimi SN, White AM, Holdiness LJ, Reiner BC, Gipson CD.Corley C, et al.Pharmacol Biochem Behav. 2024 Oct;243:173836. doi: 10.1016/j.pbb.2024.173836. Epub 2024 Jul 26.Pharmacol Biochem Behav. 2024.PMID:39067531Review.
- Effect of chronic vapor nicotine exposure on affective and cognitive behavior in male mice.Murdaugh LB, Miliano C, Chen I, Faunce CL, Natividad LA, Gregus AM, Buczynski MW.Murdaugh LB, et al.Sci Rep. 2024 Mar 19;14(1):6646. doi: 10.1038/s41598-024-56766-z.Sci Rep. 2024.PMID:38503831Free PMC article.
- Pharmacokinetic differences in nicotine and nicotine salts mediate reinforcement-related behavior: an animal model study.Han P, Jing X, Han S, Wang X, Li Q, Zhang Y, Yu P, Liu XA, Wu P, Chen H, Hou H, Hu Q.Han P, et al.Front Neurosci. 2023 Nov 16;17:1288102. doi: 10.3389/fnins.2023.1288102. eCollection 2023.Front Neurosci. 2023.PMID:38033549Free PMC article.
- Withdrawal: A key consideration in evaluating whether highly processed foods are addictive.Parnarouskis L, Leventhal AM, Ferguson SG, Gearhardt AN.Parnarouskis L, et al.Obes Rev. 2022 Nov;23(11):e13507. doi: 10.1111/obr.13507. Epub 2022 Oct 5.Obes Rev. 2022.PMID:36196649Free PMC article.Review.
- Vascularized liver-on-a-chip model to investigate nicotine-induced dysfunction.Wang E, Andrade MJ, Smith Q.Wang E, et al.Biomicrofluidics. 2023 Dec 27;17(6):064108. doi: 10.1063/5.0172677. eCollection 2023 Dec.Biomicrofluidics. 2023.PMID:38155919Free PMC article.
References
- Akimoto H, Oshima S, Michiyama Y, et al. (2018) Metabolic Profiling of the Hippocampus of Rats Experiencing Nicotine-Withdrawal Symptoms. Biol Pharm Bull 41(12): 1879–1884. - PubMed
- Alijevic O, McHugh D, Rufener L, et al. (2020) An electrophysiological characterization of naturally occurring tobacco alkaloids and their action on human α4β2 and α7 nicotinic acetylcholine receptors. Phytochemistry 170: 112187. - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Medical